Akoya Biosciences Statistics
Share Statistics
Akoya Biosciences has 49.56M shares outstanding. The number of shares has increased by 0.86% in one year.
| Shares Outstanding | 49.56M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.13% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 20.61M |
| Failed to Deliver (FTD) Shares | 3.66K |
| FTD / Avg. Volume | 0.64% |
Short Selling Information
The latest short interest is 1.60M, so 3.23% of the outstanding shares have been sold short.
| Short Interest | 1.60M |
| Short % of Shares Out | 3.23% |
| Short % of Float | 7.77% |
| Short Ratio (days to cover) | 13.43 |
Valuation Ratios
The PE ratio is -3.42 and the forward PE ratio is -5.8.
| PE Ratio | -3.42 |
| Forward PE | -5.8 |
| PS Ratio | 2.24 |
| Forward PS | 1.2 |
| PB Ratio | 4.03 |
| P/FCF Ratio | -3.97 |
| PEG Ratio | n/a |
Enterprise Valuation
Akoya Biosciences Inc. has an Enterprise Value (EV) of 219.42M.
| EV / Earnings | -3.47 |
| EV / Sales | 2.27 |
| EV / EBITDA | -4.81 |
| EV / EBIT | -3.8 |
| EV / FCF | -4.02 |
Financial Position
The company has a current ratio of 3.45, with a Debt / Equity ratio of 1.4.
| Current Ratio | 3.45 |
| Quick Ratio | 2.94 |
| Debt / Equity | 1.4 |
| Total Debt / Capitalization | 58.33 |
| Cash Flow / Debt | -0.68 |
| Interest Coverage | -6.58 |
Financial Efficiency
Return on equity (ROE) is -1.18% and return on capital (ROIC) is -41.37%.
| Return on Equity (ROE) | -1.18% |
| Return on Assets (ROA) | -0.35% |
| Return on Capital (ROIC) | -41.37% |
| Revenue Per Employee | 292.83K |
| Profits Per Employee | -191.89K |
| Employee Count | 330 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.26 |
Taxes
| Income Tax | 40.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -40.09% in the last 52 weeks. The beta is 1.35, so Akoya Biosciences 's price volatility has been higher than the market average.
| Beta | 1.35 |
| 52-Week Price Change | -40.09% |
| 50-Day Moving Average | 2.52 |
| 200-Day Moving Average | 2.76 |
| Relative Strength Index (RSI) | 52.22 |
| Average Volume (20 Days) | 573.49K |
Income Statement
In the last 12 months, Akoya Biosciences had revenue of 96.63M and earned -63.32M in profits. Earnings per share was -1.43.
| Revenue | 96.63M |
| Gross Profit | 56.30M |
| Operating Income | -57.67M |
| Net Income | -63.32M |
| EBITDA | -45.63M |
| EBIT | -57.67M |
| Earnings Per Share (EPS) | -1.43 |
Balance Sheet
The company has 83.13M in cash and 85.71M in debt, giving a net cash position of -2.58M.
| Cash & Cash Equivalents | 83.13M |
| Total Debt | 85.71M |
| Net Cash | -2.58M |
| Retained Earnings | -230.07M |
| Total Assets | 129.97M |
| Working Capital | 48.87M |
Cash Flow
In the last 12 months, operating cash flow was -50.90M and capital expenditures -3.65M, giving a free cash flow of -54.55M.
| Operating Cash Flow | -50.90M |
| Capital Expenditures | -3.65M |
| Free Cash Flow | -54.55M |
| FCF Per Share | -1.23 |
Margins
Gross margin is 58.27%, with operating and profit margins of -59.68% and -65.53%.
| Gross Margin | 58.27% |
| Operating Margin | -59.68% |
| Pretax Margin | -65.49% |
| Profit Margin | -65.53% |
| EBITDA Margin | -47.22% |
| EBIT Margin | -59.68% |
| FCF Margin | -56.45% |
Dividends & Yields
AKYA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -53.76% |
| FCF Yield | -41.38% |
Analyst Forecast
The average price target for AKYA is $3.5, which is 31.6% higher than the current price. The consensus rating is "Hold".
| Price Target | $3.5 |
| Price Target Difference | 31.6% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
Scores
| Altman Z-Score | -2.44 |
| Piotroski F-Score | 3 |